Trending...
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- New Bethany, Provident Bank, Jaindl Farms and Lehigh Valley IronPigs Unite for Turkey Drive
FAYETTEVILLE, Ark. - PennZone -- FAYETTEVILLE, Ark. – Lineus Medical announces the completion of a $4.579 million Series C funding round. The Series C round allowed Lineus Medical to expand its sales and clinical education team, secure international regulatory clearances, and obtain additional U.S. and international patents which positions the organization for continued growth and expansion. Since its founding in 2015, Lineus Medical has raised a total of $11.5 million, supporting the continued development and commercialization of its flagship product, SafeBreak® Vascular.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The PennZone
Vance Clement, Lineus Medical's CEO stated, "Our investors have seen us through the trials and tribulations of starting a medical device business, obtaining FDA De Novo clearance for a new class of product, and completing several successful clinical trials. We continue to gain customers and gain market traction. We thank our investors for their support through the pandemic and over the past three years, which has been a very difficult market to raise funds. Our investors believe, as does the Lineus Medical team, that this is only the beginning. We will continue to strive to make break-away devices the new standard of care for IV lines, and SafeBreak the preferred choice of nurses around the world.
We would also like to thank the hospitals and nurses that are our customers. Without you, we are nothing. You are the early adopters and the innovators that show your patients that you care by reducing needlesticks and IV restarts. It takes vision, guts and determination to evaluate and bring new technology into your hospital. We thank you.
More on The PennZone
With these funds, we will continue to expand our customer base, lower the manufacturing cost and price of our product, and conduct clinical research showing the value of break-away devices for all types of IV lines and patients of all ages."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on The PennZone
- 6,238 executives took new roles at US nonprofits from June to October 2026
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
- LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
- Woodside Village Joins Corner Property Management Following CMP Acquisition
- 20-Year Crash Cost of Signalized RC3 Cloverleaf Could Exceed $25 Million
Vance Clement, Lineus Medical's CEO stated, "Our investors have seen us through the trials and tribulations of starting a medical device business, obtaining FDA De Novo clearance for a new class of product, and completing several successful clinical trials. We continue to gain customers and gain market traction. We thank our investors for their support through the pandemic and over the past three years, which has been a very difficult market to raise funds. Our investors believe, as does the Lineus Medical team, that this is only the beginning. We will continue to strive to make break-away devices the new standard of care for IV lines, and SafeBreak the preferred choice of nurses around the world.
We would also like to thank the hospitals and nurses that are our customers. Without you, we are nothing. You are the early adopters and the innovators that show your patients that you care by reducing needlesticks and IV restarts. It takes vision, guts and determination to evaluate and bring new technology into your hospital. We thank you.
More on The PennZone
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
- Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
With these funds, we will continue to expand our customer base, lower the manufacturing cost and price of our product, and conduct clinical research showing the value of break-away devices for all types of IV lines and patients of all ages."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
References:
1. Data on File
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on The PennZone
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
- New Bethany, Provident Bank, Jaindl Farms and Lehigh Valley IronPigs Unite for Turkey Drive
- Grace Montessori School Awarded $56,180 to Support Scholarships for 15 Students
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- Brother Marcus Celebrates 400th Episode of The Elements of Inspiration Podcast
- USA Dental Edge Unveils Dental Intelligence
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- An AI Plays Kenshi Entirely by Itself, Live 23 Hours a Day, With an AI Host and Chat Voting
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
- Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
- Meals on Wheels of the Greater Lehigh Valley Raises Over $50,000 to Help Feed Local Seniors
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices

